Internal Server Error

Cenix BioScience - About the company

Cenix BioScience is a funded company based in Dresden (Germany), founded in 1999 by Christophe Echeverri. It operates as a Limited information available. The company has 373 active competitors, including 41 funded and 54 that have exited. Its top competitors include companies like Novartis, Catalent and Surrozen.
Key Metrics
Founded Year
1999
Location
Dresden, Germany
Stage
Funding Raised
Ranked
Employee Count
2 as on Jul 31, 2026
Similar Companies
Sign up to download Cenix BioScience's company profile

Cenix BioScience's funding and investors

Cenix BioScience is a funded company. Cenix BioScience has 2 institutional investors.

Cenix BioScience's founders and board of directors

Founder? Claim Profile
The founders of Cenix BioScience is Christophe Echeverri.
Here are the details of Cenix BioScience's key team members:

Cenix BioScience's employee count trend

Cenix BioScience has 2 employees as of Jul 26. Here is Cenix BioScience's employee count trend over the years:
Employee count trend for Cenix BioScience
lockUncover Cenix BioScience's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Cenix BioScience's Competitors and alternates

Top competitors of Cenix BioScience include Novartis, Catalent and Surrozen. Here is the list of Top 10 competitors of Cenix BioScience, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Novartis
Novartis
1996, Basel (Switzerland), Acquired
R&D focused on manufacturing of drugs for multiple therapeutic areas
-
71/100
2nd
Logo for Catalent
Catalent
2007, Somerset (United States), Acquired
Provider of development, manufacturing, and packaging solutions for medicines and supplements
-
68/100
3rd
Logo for Surrozen
Surrozen
2016, San Francisco (United States), Public
Pioneering targeted regenerative antibodies to repair tissue and restore organ function
$133M
59/100
4th
Logo for Biofortuna
Biofortuna
2008, Birkenhead (United Kingdom), Series A
Provider of manufacturing services for immunoassays, molecular diagnostics, and regulatory services
$21.6M
55/100
5th
Logo for Acclinate
Acclinate
2020, Birmingham (United States), Series A
Provider of clinical trial services to biopharma sector
$15.5M
55/100
6th
Logo for Curia
Curia
1991, Albany (United States), Acquired
Provider of drug research & development, testing, and consulting services
-
53/100
7th
Logo for Sunflower Therapeutics
Sunflower Therapeutics
2018, Hingham (United States), Series A
Provider of drug development & research services for multiple therapeutic areas
$5.64M
52/100
8th
Logo for WuXi Biologics
WuXi Biologics
2008, Shanghai (China), Public
Developer and manufacturer for protein therapeutics
-
52/100
9th
Logo for BioFactura
BioFactura
2004, Frederick (United States), Series B
Biosimilars, biodefense, and biomanufacturing company dedicated to innovation and global biomedical needs
$7.8M
51/100
10th
Logo for Ventus Therapeutics
Ventus Therapeutics
2019, Boston (United States), Series C
Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment
$300M
51/100
197th
Logo for Cenix BioScience
Cenix BioScience
1999, Dresden (Germany), Funding Raised
Limited information available
-
20/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Cenix BioScience's competitors? Click here to see the top ones

Cenix BioScience's Investments and acquisitions

Cenix BioScience has made no investments or acquisitions yet.

Reports related to Cenix BioScience

Here is the latest report on Cenix BioScience's sector:

FAQs about Cenix BioScience

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford